May 25, 2010
Recently, there have been a number of new investment deals taking place throughout the airline, green energy and pharmaceutical industries. Within the airline industry, Avolon has announced new investments totaling more than $1 billion. Within the green energy industry, BrightSource Energy, Inc. announced over $100 million in new venture capital, all while the biopharmaceutical company NeuroTherapeutics Pharma, Inc. announced more than $40 million in new capital investments. The variety of industries receiving new venture capital is an important sign regarding the overall health of the global market place for investment and growth opportunities.
The biopharmaceutical company NeuroTherapeutics Pharma, Inc. recently announced the closing of its Series B round of financing, which totaled $43 million. The Chicago, Illinois-based firm focuses on developing new treatments for a variety of disorders involving the central nervous system. Currently, the market for new treatments for central nervous system disorders, such as Alzheimerâ€™s, multiple sclerosis and Huntingtonâ€™s disease, is in high demand. Investors involved in the newest round of financing include Fidelity Bioscience, SR One, Pfizer and MPM Capital. Past investors, who also invested capital in this latest round, include Thomas McNerney & Partners and Novo Ventures. The new venture capital comes in concert with NeuroTherapeuticsâ€™ plan to expand its manufacturing capabilities.
Another company making news is the solar power utility BrightSource Energy, Inc. BrightSource recently announced that is has raised $150 million dollars from a variety of investors in its Series D round of financing. This new capital brings this Oakland, California-based company a total of $300 million in venture capital. As a leader in the industry, BrightSource is in the perfect situation to increase its market share. The new capital will go towards the advancement of the companyâ€™s partnership with utility giants Pacific Gas and Electric and Southern California Edison to develop over a dozen solar power plants across the U.S. over the next few years. The new round of financing includes both old and new investors, including Draper Fisher Jurvetson, the California State Teachers Retirement System and Alstom, whose investment with BrightSource could reach $55 million.
Although $150 million in venture capital is a sizable chunk of change, Avolon, an increasingly important player in the aircraft leasing business, recently announced the completion of raising $1.4 billion in initial capital. The Dublin, Ireland-based Avolon is in the works to purchase over two dozen aircraft for future leasing purposes. Avolon, which has acquired a well versed group of individuals to run the company, seeks to capitalize on its internal expertise to become a leading player within the large market for aircraft leasing, which handles the financing for 40% of all new aircraft deliveries. Of the $1.4 billion, major private equity firms contributed $750 million, $400 million came from a number of major banks and an additional $215 million comes from Germanyâ€™s DVB Bank.
Although raising capital may not seem like an easy task, the examples provided by NeuroTherapeutuics, BrightSource and Avolon prove that it is not an impossible task. To further improve your chances of getting the venture capital that you or your small business need by getting VCgateâ€™s Venture Capital and Investors Database today! VCgateâ€™s catalog includes 791 individuals or firms providing capital to biotechnology companies, 286 opportunities for those within the energy industry and 686 individuals of firms providing investment capital within the business services sector. Do not let this opportunity pass you by. Take advantage of this great resource and take your business to the next level today!
( and click Like if you like :-) )
Then Follow us @ //twitter.com/vcgate